Lumida
/LYEL
⌘K
Lyell Immunopharma Inc

Lyell Immunopharma Inc

LYEL
$11.96USD-1.97%-0.24 today

MARKET CAP

293.1M

P/E (TTM)

FWD P/E

DAY RANGE

$12 – $13

52W RANGE

$11
$45
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$10.7M$84.7M$130,000$61,000$36,000
YoY %+695.1%-99.8%-53.1%-41.0%
P / Sales98.8x9.8x4073.6x2743.4x14614.5x
EV / Sales89.7x9.6x3684.6x2783.4x15494.2x
Gross Profit, Adj.$10.7M$84.7M$130,000$61,000$36,000
YoY %+695.1%-99.8%-53.1%-41.0%
Margin %100.0%100.0%100.0%100.0%100.0%
EV / Gross Profit89.7x9.6x3684.6x2783.4x15494.2x
EBITDA, Adj.$-201.2M$-169.0M$-229.5M$-204.0M$-192.2M
YoY %+16.0%-35.8%+11.2%+5.7%
Margin %-1888.8%-199.6%-176575.4%-334347.5%-533986.1%
EV / EBITDA-4.8x-4.8x-2.1x-0.8x-2.9x
EBIT$-214.8M$-187.1M$-249.8M$-362.1M$-271.5M
YoY %+12.9%-33.5%-44.9%+25.0%
Margin %-2016.7%-220.9%-192152.3%-593547.5%-754302.8%
EV / EBIT-4.5x-4.3x-1.9x-0.5x-2.1x
Net Income$-250.2M$-183.1M$-234.6M$-343.0M$-274.4M
YoY %+26.8%-28.1%-46.2%+20.0%
Net Margin-2349.5%-216.2%-180486.2%-562285.2%-762355.6%
EPS (GAAP)-$36.80-$14.80-$18.70-$26.23-$16.06
YoY %+59.8%-26.4%-40.3%+38.8%